B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLC1A1

MOLECULAR TARGET

solute carrier family 1 member 1

UniProt: P43005NCBI Gene: 65052 compounds

SLC1A1 (solute carrier family 1 member 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLC1A1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Glutamic Acid1.393
2Glutamic Acid1.393

About SLC1A1 as a Drug Target

SLC1A1 (solute carrier family 1 member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented SLC1A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLC1A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.